New England Biolabs ® Proudly Partners with Automation Providers to Support NGS Library Prep Automation Globally

IPSWICH, Mass., Feb. 6, 2026 /PRNewswire/ -- New England Biolabs (NEB ®) will present several scientific posters at this week's Society for Laboratory Automation and Screening (SLAS) meeting in Boston, MA, highlighting collaborations with leading laboratory liquid-handling automation providers, including Beckman Coulter Genomics, Eppendorf, Hamilton Company, Revvity, and SPT Labtech to support customer implementation of NEBNext® reagents for next-generation sequencing (NGS) library preparation.

According to Michael Benway, Sr. Automation Field Application Scientist for NEB, "As the manufacturer of reagents for NGS library prep, we seek to enable automation providers by working collaboratively on workflows and scripts for library prep methods that demonstrate equivalent or improved performance when executed on automated workstations. By leveraging the expertise of automation providers, we are then able to deploy the optimized methods globally to ensure customer success."

NEB's collaborative approach is built on close work with laboratory automation partners to automate, optimize and verify performance across a wide range of NEBNext products, including NEBNext UltraExpress® DNA and RNA Library Prep, NEBNext Enzymatic Methyl-seq (EM-seq™), and NEBNext Low-bias Small RNA Kits.

"Standardized, automation-ready workflows are critical for scaling NGS across organizations and geographies," said Michael Mouradian, Vice President of Scientific Strategy and Market Development at Hamilton Company. "Our collaboration with NEB focuses on delivering robust, transferable methods that laboratories can deploy with confidence, while reducing implementation time and validation burden."

According to Nicole Madamba, Sr. Manager of Research Applications at Revvity, "Our longstanding work with NEB has allowed us to apply our expertise to develop and deploy customer-centric automation solutions that we can support globally."

Critical for the shift to portable, globally supported workflows is the standardization and optimization of hardware and software to ensure that solutions developed can be readily shared with customers, with minimal support required to customize and validate for specific customer needs.

Paul Lomax, Genomics Leader at SPT Labtech, "By applying software development principles to protocol design, we've transformed how we collaborate with NEB. This methodology allows us to build more robust NGS solutions that are instantly scalable and ready for immediate deployment across customer sites."

The collaborative relationships between NEB and automation providers has been longstanding and customer-focused, delivering high-quality results for scientists worldwide, "Our partnership with NEB has always been driven by the shared goal of solving customer problems, and our collective commitment, leveraging both the Biomek and Echo liquid handlers, has empowered us to overcome some of the most significant challenges in automated NGS," according to Ewan Grant, Senior Director, Automation Portfolio, Beckman Coulter Life Sciences.

Collaborative work being presented at the upcoming SLAS 2026 meeting includes:

Poster: 1360-A
NEBNext® UltraShear FFPE DNA Library Prep Kit Automated on Revvity Sciclone™ G3 NGSx Workstation

Poster: 1211-B
Automation of NEBNext® UltraExpress® DNA Library Prep Kit on Revvity Sciclone™ G3 NGSx Workstation with Low Input cfDNA in Collaboration with a Medical Research Institution

Poster: 1206-B
Automation and Verification of the NEBNext® Enzymatic Methyl-seq v2 (EM-seq v2) Library Preparation Workflow on the Revvity Sciclone™ G3 NGSx Workstation at the Yale Center for Genome Analysis

Poster: 1207-C
Automation of NEBNext® Ultra II FS using Unique Molecular Indexes with Revvity Sciclone™ G3 NGSx Workstation

Poster: 1209-E
Automation of NEBNext® Ultra™ II RNA Library Prep Kit for Illumina® and the NEBNext® Poly(A) mRNA Magnetic Isolation Module® on SPT LabTech firefly® Workstation at Weil Cornell Medical School Genomics Core

For more information and a list of available automation solutions for NEBNext products, please visit www.neb.com/automation

About New England Biolabs

For over 50 years, New England Biolabs (NEB) has pioneered the discovery and production of innovative products tailored for molecular biology research. Our commitment to scientific discovery is evident in all that we do, including our ever-expanding product portfolio, investment in our basic and applied research program, and support of customers' research in academia and industry, including cutting-edge technologies for use in molecular diagnostics and nucleic-acid vaccines development. Guided by our founding principles, NEB proactively invests in efforts to improve the well-being of our employees, surrounding communities, as well as the future of our planet. NEB remains a privately held company with global reach, supported by our headquarters in Ipswich, MA, USA, subsidiary offices in 10 countries, and over 60 distribution partners around the world. For more information about New England Biolabs, visit www.neb.com.

NEW ENGLAND BIOLABS®, NEB®, NEBNEXT® and NEBNEXT ULTRAEXPRESS ® are registered trademarks of New England Biolabs, Inc.

Biomek and Echo Automated Workstations are not intended or validated for use in the diagnosis of disease or other conditions.

SOURCE New England Biolabs, Inc.